Pacific Biosciences of California PACB Loss on purchase commitment
Loss on purchase commitment at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept pacb:LossOnPurchaseCommitment.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's loss on purchase commitment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's loss on purchase commitment?
- Pacific Biosciences of California (PACB) reported loss on purchase commitment of $0 in Q1 2026.
- How has Pacific Biosciences of California's loss on purchase commitment changed year-over-year?
- Pacific Biosciences of California's loss on purchase commitment decreased by 100.0% year-over-year, from $4.07M to $0.
- What is the long-term trend for Pacific Biosciences of California's loss on purchase commitment?
- Over 3 years (2022 to 2025), Pacific Biosciences of California's loss on purchase commitment has grown at a 4.1% compound annual growth rate (CAGR), from $3.71M to $4.18M.
- What does loss on purchase commitment mean?
- This captures losses recognized when the company is obligated to purchase inventory or services at prices higher than the current market value or net realizable value. It serves as an indicator of supply chain inefficiencies or unfavorable long-term procurement contracts. High values suggest potential over-commitment or a decline in the market value of inputs.